AACR CEO Margaret Foti to Receive Prestigious Beacon Award for Women Leaders in Oncology
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), has been selected...
Search/Filter
Loading...
AACR, ASA, and FDA Outline Considerations for Overall Survival Analyses in Clinical Trials
New article in Clinical Cancer Research lists best practices, novel statistical methods, and suggestions for improving benefit-risk assessments PHILADELPHIA...
Patients Receiving Protocol Exceptions to Participate in Targeted Therapy Trial Experienced Similar Outcomes as Eligible Participants
Study highlights potential benefits of broadening eligibility criteria for clinical trials PHILADELPHIA – Patients with treatment-refractory cancers who received...
AACR Chief Philanthropic Officer Mitch Stoller to Receive 2024 Change Our Future Game Changer Award
Stoller will be recognized tonight at the 4th annual Sneaker Ball, hosted by former Eagle Rodney McLeod Jr. and...
Among Cancer Survivors, LGBTQ+ Individuals Report Higher Prevalence of Chronic Health Conditions, Disabilities, Other Limitations
Transgender or gender non-conforming cancer survivors had higher odds of most conditions compared to cisgender cancer survivors PHILADELPHIA –...
Trametinib Shows Promise for Children with Relapsed or Refractory JMML
PHILADELPHIA – The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile...
HPV Testing for Cervical Cancer May Be Safe at Longer Intervals Than What Current Guidelines Recommend
HPV testing eight years after a negative result instead of the recommended five was found comparable to standard cytology...
AACR Releases Cancer Disparities Progress Report 2024
Report features latest statistics and nine compelling patient stories PHILADELPHIA — The American Association for Cancer Research (AACR) today...
Culturally Sensitive Video Targeting Black Men May Help Increase Awareness About Prostate Cancer
SAN DIEGO – A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants...
Proteogenomic Signatures May Help Identify Risk of Prostate Cancer Progression in Patients with African and European Ancestries
SAN DIEGO – Certain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated...